Work

CpG Island Methylation Is a Poor Prognostic Factors in Myelodysplastic Syndrome Patients and Is Reversed by Decitabine Therapy-Results of a Phase III Randomized Study.

Year: 2005

Type: article

Source: Blood

DOI: 10.1182/blood.v106.11.790.790

Authors: Lanlan Shen, Hagop Kantarjian, Hussain Saba, E. Lin, Don Berry, Saira Ahmed, Jaroslav Jelinek, Jean-Pierre J. Issa

Institutions: The University of Texas MD Anderson Cancer Center, Moffitt Cancer Center

Language: English

Topic: Epigenetics and DNA Methylation

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2564104539

FWCI: 0.923

Cites:

Cited by: 8

Related to: 10